R. Bryan Bell, MD, DDS, FACS, is Physician Executive and Director, Division of Surgical Oncology, Radiation Oncology and Program Development at Providence Health & Services-Oregon; Medical Director of the Providence Head and Neck Cancer Program and Clinic, and Associate Member & Director of Surgical Oncology Research at the Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center in the Providence Cancer Institute. As a head and neck oncologic surgeon, Dr. Bell’s research is directed toward enhancing surgical resection with both biologically and technologically advanced therapies. He and his scientific collaborators focus on modulating the tumor microenvironment prior to surgery by reversing immunosuppression through monoclonal antibodies, vaccines and bioengineered materials for local drug delivery. In addition, Dr. Bell leverages team science to apply a multi-omics approach for immune profiling of head and neck cancer with goal of delivering personalized immunotherapy. Using his surgical practice to run novel phase I and phase II clinical trials in the neoadjuvant setting, Dr. Bell bridges basic, translational and clinical activities. Dr. Bell has also contributed to the clinical development of virtual surgical planning, transoral robotic surgery, and sentinel lymph node biopsy for patients with head and neck cancer. His work has resulted in over 150 scientific articles and book chapters, and he is co-editor of two major textbooks, including Oral, Head and Neck Oncology and Reconstructive Surgery.